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affecting millions of patients worldwide. Studies showing
strong associations between mucosal healing and increased
patient survival point towards tissue repair as a target of
novel therapeutic strategies. Using a mouse model of
intestinal inflammation and repair (DSS-induced colitis),
we performed an unbiased transcriptomic time-series
analysis to identify novel potential therapeutical pathways
related to mucosal healing. Briefly, we collected colonic
tissues at different time points (from steady-state to
inflammation to recovery) and processed them for RNA-
seq, histology and FACS analysis. Transcriptional analysis
on the differentially expressed genes identified 14 different
expression patterns over time (clusters), among which 5 of
them combined explain more than 65% of the variance
observed in the experiment. Gene set enrichment analysis
revealed that these 5 clusters contained mostly genes
involved in cell migration, cytokine production, defence
response to bacteria, angiogenesis and wound repair. FACS
and histological analysis on the colon tissue corroborated
the RNA-seq analysis, showing transient increase in
neutrophil, T cell and monocyte recruitment at different
time points and ultimately resulting in remodelling of
tissue architecture towards repair. Surprisingly, processes
such as cholesterol metabolism and RNA processing were
also enriched concomitantly with the recovery phase,
suggesting a potential role in inducing tissue regeneration.
Altogether, time series analysis during intestinal inflam-
mation suggests potential therapeutic targets that might
influence mucosal healing after colonic inflammation.
A-31451
GP2 is selectively expressed by small
intestinal CD103+CD11b+ cDC
Katarzyna Mu¨ller-Luda1, Fatemeh Ahmadi1,
Hiroshi Ohno2,3, Knut Kotarsky1 & William W.
Agace1,4
1Immunology Section, Lund University, Lund, Sweden, 2Division of
Immunobiology, Graduate School of Supramolecular Biology, Yokohama
City University, Yokohama, Kanagawa, Japan, 3Laboratory for Intestinal
Ecosystem, RIKEN Center for Integrative Medical Sciences, Kanagawa,
Japan, and 4Section for Immunology and Vaccinology, National Veterinary
Institute, Technical University of Denmark, Copenhagen, Denmark
The functionality of tissue cDC is regulated, at least in
part, by the signals these cells receive within their local
environment. For example, we and others, have demon-
strated that murine small intestinal but not colonic cDC
are imprinted with an ability to generate the Vitamin A
metabolite, retinoic acid, and thus an enhanced capacity to
drive the generation of small intestinal homing T cells.
Here we demonstrate that Glycoprotein 2 (GP2), a GPI-
anchored protein previously shown to be selectively
expressed by M-cells and to act as a receptor for type 1
fimbriated bacteria (1), is expressed by a large proportion of
IRF4-dependent cDC in the small intestine but not in
other tissues. While surface expression of GP2 by small
intestinal CD103+CD11b+ cDC was independent of
lymphocytes and MyD88 signaling, administration of
broad spectrum antibiotics increased the proportion of
GP2+CD103+CD11b+ cDC in the small intestine. More-
over, GP2 expressing cDC in the small intestine were
dramatically reduced in the setting of intestinal inflam-
mation. We have previously shown that mice with an IRF4
deletion in CD11c+ cells (Cd11c-cre.Irf4 fl/fl mice) have
reduced numbers of small intestinal CD103+CD11b+ cDC
(2). Interesting, we found that GP2+ CD103+CD11b+ cDC
were dramatically reduced in these mice. Finally, to address
the in vivo role of GP2 expression by cDC, we have
generated mice with a selective deletion of GP2 in
CD103+CD11b+ cDC (huLangerin-cre.gp2 fl/fl mice).
Results from these ongoing studies will be presented.
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The applicability of a new saponin adjuvant formulation
(G3) was tested in cultures of equine peripheral blood
mononuclear cells (eqPBMCs). When immunizing mice
with a split influenza vaccine the inclusion of this adjuvant
could enhance the antibody response, as well as induce
CD8+CD3+ T-cells and a broad protection against
influenza challenge when a diterpene was incorporated in
the G3 formula (van de Sandt et al., Vaccine. 2014 32:
5614–23.). Therefore, the present study aimed to evaluate
cytokine responses to G3 alone or in combination with
other immunostimulatory compounds. EqPBMC exposed
to G3 for 18 h displayed an increased expression of the
genes encoding IL-12p40 and IFN-c (Th1), IL-23p19
(Th17), as well as IL-8 and IL-1b (pro-inflammatory). This
G3-induced cytokine expression profile could be modified
by co-culturing eqPBMC with G3 and known agonists to
TLR5 (Flagellin) or TLR2/1 (Pam3CSK4). The combina-
tion of G3 with Pam3CSK4 increased the IFN-c response
compared to that induced by G3 or Pam3CSK4 alone. A
similar increase in gene expression of IL-8 was indicated
when G3 was combined with Flagellin. In contrast, the
presence of G3 reduced the expression of the
Scandinavian Journal of Immunology, 2017, 86, 250–350
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